Response to RET-Specific Therapy in RET Fusion-Positive Anaplastic Thyroid Carcinoma

Background: Anaplastic thyroid carcinoma (ATC) remains one of the most challenging malignancies to treat in the modern era. Most patients present with or develop recurrent/metastatic incurable disease with poor response rates to conventional chemotherapy, and life expectancy is short. Next-generatio...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Thyroid
Auteurs principaux: Dias-Santagata, Dora, Lennerz, Jochen K., Sadow, Peter M., Frazier, Ryan P., Govinda Raju, Sandya, Henry, Dahlia, Chung, Trisha, Kherani, Jennifer, Rothenberg, S. Michael, Wirth, Lori J.
Format: Artigo
Langue:Inglês
Publié: Mary Ann Liebert, Inc., publishers 2020
Sujets:
Case Studies, and Patients with Remarkable Features or Rare Disorders
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7482117/
https://ncbi.nlm.nih.gov/pubmed/32292131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/thy.2019.0477
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires